Organogenesis Holdings
ORGO
115 hedge funds and large institutions have $176M invested in Organogenesis Holdings in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 27 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 30
9% more capital invested
Capital invested by funds: $162M → $176M (+$14M)
4.2% more ownership
Funds ownership: 43.24% → 47.44% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 124 → 115 (-9)
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
86% less call options, than puts
Call options by funds: $18K | Put options by funds: $127K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$8.07M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.22M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.65M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$949K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$894K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$1.22M |
| 2 |
HF
HRT Financial
New York
|
-$905K |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$651K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$601K |
| 5 |
Two Sigma Investments
New York
|
-$543K |
ORGO Hedge Fund Activity: Q2 2024 in Review
115 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2024, worth a combined $176M — up 8.7% from $162M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of ORGO and 18 opened new positions — a net loss of 9 holders — while 30 trimmed existing stakes and 52 added.
The largest buyer was Assenagon Asset Management, adding an estimated $8.07M. The largest seller was Thompson Siegel & Walmsley, exiting entirely with an estimated $1.22M sold.
- 115 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2024, down from 124 in Q1 2024.
- Funds reported $176M of Organogenesis Holdings stock for Q2 2024, up 8.7% quarter-over-quarter.
- 18 funds opened new Organogenesis Holdings positions in Q2 2024 and 27 closed out, a net change of -9 holders.
- The largest Organogenesis Holdings buyer in Q2 2024 was Assenagon Asset Management, an estimated $8.07M added.
- The largest Organogenesis Holdings seller in Q2 2024 was Thompson Siegel & Walmsley, an estimated $1.22M sold.
Based on aggregated 13F filings for Q2 2024.